News
Investor's Business Daily on MSN
Stock Market Today: Dow Up As Powell Outlines 'Risk-Management Cut' In 'Challenging Situation' (Live Coverage)
Volume turned higher on the New York Stock Exchange and Powell's 'Rick-Management Cut' Powell during his afternoon press ...
UCB, a global biopharmaceutical company, today announced three-year data from the BE HEARD trials for BIMZELX® (bimekizumab-bkzx) in adults with moderate-to-severe hidradenitis suppurativa (HS).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback